May 12, 2023 Columns by Ed Tobias My 5 wishes for the future of multiple sclerosis A recent post on the MS-Selfie blog asks and answers this question: What is the “greatest unmet need” concerning multiple sclerosis (MS)? Professor Gavin Giovannoni, the London-based neurologist who writes that blog, lists five unmet…
May 8, 2023 Columns by Ed Tobias MS news notes: Ocrevus, assistive devices, virtual reality, Briumvi Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Study: Starting Ocrevus early…
May 5, 2023 Columns by Ed Tobias Artificial intelligence moves into the MS exam room. But should it? Is artificial intelligence (AI) intelligent enough to help make a diagnosis of multiple sclerosis (MS)? Apparently so, and more. In the United Kingdom, a project named AssistMS is studying whether AI can be…
May 1, 2023 Columns by Ed Tobias MS news notes: Stem cell therapy, early Aubagio use, DMTs Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Today I’ll focus on stories from the American Academy of…
April 28, 2023 Columns by Ed Tobias If you have MS, is it time to get another COVID-19 booster? Those with multiple sclerosis (MS) may want to roll up their sleeves again for a COVID-19 vaccine. I’m thinking about whether to join them. About 10 days ago, an advisory committee of the U.S.
April 24, 2023 Columns by Ed Tobias MS news notes: Yoga, vitamin D, myelin repair, fall risk Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Yoga vs. physical therapy…
April 21, 2023 Columns by Ed Tobias Lucky me, with light injuries after falling while riding a scooter Oops! I took a turn too fast in the parking lot of my condo the other morning and tipped to the left. And with that, my mobility scooter and I headed for a fall. Do…
April 17, 2023 Columns by Ed Tobias MS news notes: EBV vaccine trial, DMT costs, Mavenclad, evobrutinib Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: EBV vaccine trial could…
April 14, 2023 Columns by Ed Tobias Will layoffs at Biogen affect its focus on multiple sclerosis treatments? Biogen has been a top dog in the multiple sclerosis (MS) treatment field for decades. The pharmaceutical giant developed Avonex (interferon beta-1a), approved in the U.S. in 1996 as one of the first…
April 10, 2023 Columns by Ed Tobias MS news notes: Sativex, Octopus ‘mega-trial’, Ocrevus, snuff Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Good patient reviews for…
April 7, 2023 Columns by Ed Tobias What my spring training looks like with MS My exercise routine was first disrupted by the pandemic. Then Hurricane Ian landed a right hook on the exercise room in my Florida community, knocking it out of action. But not long after that, my thoughts were…
April 3, 2023 Columns by Ed Tobias MS news notes: Orelabrutinib, foralumab, diets, coffee and tea Welcome to “MS News Notes,” a Monday morning column in which I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: A positive report…
March 31, 2023 Columns by Ed Tobias That UTI — was it caused by MS or was it the meat? Many people with multiple sclerosis (MS) have experienced urinary tract infections (UTIs) at some point. It’s a common problem with MS and can be caused by a number of things, such as the inability to fully empty…
March 27, 2023 Columns by Ed Tobias MS News Notes: Briumvi, COVID-19, PML, disability rights victory Note: This column was updated March 30, 2023, to remove the statement that Briumvi is more potent than Ocrevus or Kesimpta as there have been no trials comparing the three therapies’ potency. Welcome to “MS News…
March 24, 2023 Columns by Ed Tobias Is preboarding travelers with disabilities a good thing or not? Boarding an aircraft before others is a small benefit to being a disabled flyer. For years, giving me a small start to get down the jetway ahead of even the most frequent of frequent flyers has given me time…
March 20, 2023 Columns by Ed Tobias MS news notes: Ocrevus, MDX-2201, online cannabis clinic, WHO Welcome to “MS News Notes,” a Monday morning column in which I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Study shows Ocrevus…
March 17, 2023 Columns by Ed Tobias 3 tools to help you choose the right MS disease-modifying therapy Choosing the best disease-modifying therapy (DMT) to treat your multiple sclerosis (MS) can be a tough decision. When I was diagnosed with MS way back in 1980, it was easy. There were no DMTs to choose…
March 13, 2023 Columns by Ed Tobias MS news notes: MSC-NP, GA Depot, AI and MRIs, aggressive treatment Welcome to “MS News Notes,” a Monday morning column in which I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: A different type…
March 10, 2023 Columns by Ed Tobias A debt of gratitude to disability rights champion Judy Heumann You may not have heard of Judy Heumann, who died March 4 at the age of 75. Although she’s not directly connected to the multiple sclerosis (MS) community, you should know about her. Everyone who lives with a…
March 6, 2023 Columns by Ed Tobias MS News Notes: Briumvi, vitamin D, CNM-Au8 Welcome to “MS News Notes,” a Monday morning column in which I comment on multiple sclerosis (MS) news stories that caught my eye last week. In this column, I’ll be highlighting more MS News…
September 28, 2023 Columns by Benjamin Hofmeister With multiple sclerosis, don’t worry about asking stupid questions
